ECSP088319A - Síntesis de inhibidores de renina que involucra una reacción de cicloadición - Google Patents

Síntesis de inhibidores de renina que involucra una reacción de cicloadición

Info

Publication number
ECSP088319A
ECSP088319A EC2008008319A ECSP088319A ECSP088319A EC SP088319 A ECSP088319 A EC SP088319A EC 2008008319 A EC2008008319 A EC 2008008319A EC SP088319 A ECSP088319 A EC SP088319A EC SP088319 A ECSP088319 A EC SP088319A
Authority
EC
Ecuador
Prior art keywords
synthesis
cycloadition
renina
reaction
inhibitors
Prior art date
Application number
EC2008008319A
Other languages
English (en)
Inventor
Wolfgang Marterer
Stuart John Mickel
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35394904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP088319(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ECSP088319A publication Critical patent/ECSP088319A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/24Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)

Abstract

La invención se refiere a un proceso novedoso, a pasos de proceso novedosos, y a intermediarios novedosos útiles en la síntesis de compuestos farmacéuticamente activos, en especial inhibidores de renina, tales como alisquireno. Entre otras cosas, la invención se refiere a un proceso para la fabricación de un compuesto de la Fórmula III, en donde R, R1, y R' son como se definen en la memoria descriptiva, o una sal del mismo, y un compuesto de la Fórmula IV, en donde R, R1, R2, y R' son como se definen en la memoria descriptiva, y a procesos para la fabricación de los mismos.
EC2008008319A 2005-09-28 2008-03-27 Síntesis de inhibidores de renina que involucra una reacción de cicloadición ECSP088319A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0519764.5A GB0519764D0 (en) 2005-09-28 2005-09-28 Organic compounds

Publications (1)

Publication Number Publication Date
ECSP088319A true ECSP088319A (es) 2008-04-28

Family

ID=35394904

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2008008319A ECSP088319A (es) 2005-09-28 2008-03-27 Síntesis de inhibidores de renina que involucra una reacción de cicloadición

Country Status (27)

Country Link
US (2) US7973175B2 (es)
EP (2) EP2287153A1 (es)
JP (1) JP2009509990A (es)
KR (1) KR20080048042A (es)
CN (1) CN101273012A (es)
AR (1) AR057137A1 (es)
AT (1) ATE492533T1 (es)
AU (1) AU2006299097B2 (es)
BR (1) BRPI0616707A2 (es)
CA (1) CA2623495A1 (es)
DE (1) DE602006019114D1 (es)
EC (1) ECSP088319A (es)
ES (1) ES2358536T3 (es)
GB (1) GB0519764D0 (es)
GT (1) GT200600427A (es)
IL (1) IL189763A0 (es)
MA (1) MA29852B1 (es)
MY (1) MY143251A (es)
NO (1) NO20082005L (es)
NZ (1) NZ566429A (es)
PE (1) PE20070488A1 (es)
PL (1) PL1931629T3 (es)
PT (1) PT1931629E (es)
RU (1) RU2423348C2 (es)
TN (1) TNSN08142A1 (es)
TW (1) TW200730480A (es)
WO (1) WO2007039183A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2062874B1 (en) 2007-11-20 2014-12-17 KRKA, tovarna zdravil, d.d., Novo mesto Process and intermediates for the preparation of aliskiren
SI2189442T1 (sl) 2008-11-20 2015-03-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek in intermediati za pripravo aliskirena
WO2011051853A1 (en) 2009-10-29 2011-05-05 CarboDesign LLC Manufacturing process for preparing enaniomerically pure 8- aryloctanoic acid derivatives such as aliskiren
CN101863796B (zh) * 2010-05-12 2011-08-24 海南美兰史克制药有限公司 一种阿利克仑化合物及其制法
EP2551260A1 (en) 2011-07-28 2013-01-30 Chemo Ibérica, S.A. Chemical process for opening ring compounds
US8703976B2 (en) 2011-10-02 2014-04-22 Milan Soukup Manufacturing process for 8-aryloctanoic acids such as Aliskiren

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421295A1 (de) 1984-06-08 1985-12-12 Basf Ag, 6700 Ludwigshafen Neue pyrrolidincarbonsaeurederivative, verfahren zu ihrer herstellung
MY119161A (en) 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
DE60138099D1 (de) 2000-07-05 2009-05-07 Speedel Pharma Ag Verfahren zur herstellung von substituierten octanoyl-amiden
DE10116816A1 (de) * 2001-04-04 2002-10-17 Basf Ag Verfahren zur Herstellung von N-Benzylaminen
GB0419361D0 (en) 2004-08-31 2004-10-06 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
EP1931629A1 (en) 2008-06-18
GB0519764D0 (en) 2005-11-09
TW200730480A (en) 2007-08-16
ATE492533T1 (de) 2011-01-15
PL1931629T3 (pl) 2011-05-31
RU2008116317A (ru) 2009-11-10
RU2423348C2 (ru) 2011-07-10
CA2623495A1 (en) 2007-04-12
JP2009509990A (ja) 2009-03-12
NO20082005L (no) 2008-06-24
AU2006299097B2 (en) 2010-11-04
AU2006299097A1 (en) 2007-04-12
EP2287153A1 (en) 2011-02-23
PT1931629E (pt) 2011-03-09
MA29852B1 (fr) 2008-10-03
DE602006019114D1 (de) 2011-02-03
US7973175B2 (en) 2011-07-05
CN101273012A (zh) 2008-09-24
EP1931629B1 (en) 2010-12-22
US20110230665A1 (en) 2011-09-22
MY143251A (en) 2011-04-15
PE20070488A1 (es) 2007-06-13
BRPI0616707A2 (pt) 2011-06-28
IL189763A0 (en) 2008-08-07
WO2007039183A1 (en) 2007-04-12
NZ566429A (en) 2010-10-29
AR057137A1 (es) 2007-11-21
GT200600427A (es) 2007-04-30
US20080255369A1 (en) 2008-10-16
ES2358536T3 (es) 2011-05-11
TNSN08142A1 (en) 2009-07-14
KR20080048042A (ko) 2008-05-30

Similar Documents

Publication Publication Date Title
ECSP088368A (es) Derivados de 3-alquil-5-(4-alquil-5-oxo-tetrahidrofuran-2-il)-pirrolidin-2-ona como intermediarios en la síntesis de inhibidores de renina
ECSP099708A (es) Nuevos métodos
MX340573B (es) Proceso para la fabricacion de compuestos farmaceuticamente activos.
ECSP077986A (es) Procedimiento para preparar inhibidores de renina
AR054818A1 (es) Proceso para preparar rosuvastatina e intermediarios
ECSP088319A (es) Síntesis de inhibidores de renina que involucra una reacción de cicloadición
AR066130A1 (es) Formas cristalinas de saxagliptina y procesos para preparar las mismas
CU23847B1 (es) 2-piperidinilo bencimidazoles útiles en el tratamiento del crecimiento celular anormal
ECSP099817A (es) Procesos para la preparacion de pirazoles
GT200700036A (es) Compuestos fenil amido heterociclicos condensados
AR057033A1 (es) Tigeciclina y metodos para preparar 9-nitrominociclina
AR047739A1 (es) Polimorfos cristalinos de un ligando receptor de cxc-quimiocina
PA8678901A1 (es) Derivados de quinolina como agentes antibacteriales
MX2009013212A (es) Proceso para la sintesis de intermediarios de los inhibidores de renina tales como alisquireno.
DOP2011000113A (es) Pirazolilaminopiridinas como inhibidores de fak
MY146084A (en) Benzyl amines, a process for their production and their use as anti-inflammatory agents
EA200600605A1 (ru) Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств
AR099594A2 (es) Proceso para preparar bisulfato de atazanavir y otras formas
TW200726752A (en) Process for the production of intermediates for the preparation of tricyclic benzimidazoles
SE0403085D0 (sv) Novel componds
EA201170736A1 (ru) Синтез и новые солевые формы (r)-3-((e)-2-(пирролидин-3-ил)винил)-5-(тетрагидропиран-4-илокси) пиридина
BRPI0406893A (pt) Derivados de acilaminotiazol, a respectiva preparação e a respectiva utilização como inibidores da produção do peptìdeo betaamilóide
WO2006074873A3 (en) New one-step synthesis of useful disubstituted amines
AR053137A1 (es) Proceso para la preparacion de anilinas
AR053439A1 (es) Proceso para la preparacion de nitrobenzoles